Skip to main content

Table 2 Patient characteristics ( whole sample and subgroups relating to experience of BCC symptoms and treatment)

From: What determines patient preferences for treating low risk basal cell carcinoma when comparing surgery vs imiquimod? A discrete choice experiment survey from the SINS trial

 

Whole sampleN=174

With no experienceN=118

With experienceN=56

With no vs.with experience

 

% (n)

% (n)

% (n)

P value

Gender

0.3

Male

60.9 (106)

63.6 (75)

55.4 (31)

 

Female

39.1 (68)

36.4 (43)

44.6 (25)

 

Age

0.1

Median [IQR]

65 [57–72]

63 [55–72]

68 [60–72]

 

Employment status

N.A. 1

Employed

35.6 (62)

39.8 (47)

26.8 (15)

 

Retired

63.2 (110)

59.3 (70)

71.4 (40)

 

Unemployed

1.2 (2)

0.9 (1)

1.8 (1)

 

Weekly income 2

0.21

<£299

50.0 (80)

44.9 (53)

48.2 (27)

 

£300-499

19.5 (34)

20.3 (24)

17.9 (10)

 

£>=500

19.5 (34)

19.5 (23)

19.6 (11)

 

(Not recorded to beexcluded from analysis)

14.9 (26)

15.3 (18)

14.3 (8)

 

Previous experience of BCC symptoms and treatment

Yes

32.2 (56)

0 (0)

100 (56)

 

No

67.8 (118)

100 (118)

0 (0)

 

Difficulties in completing the questionnaire

N.A. 1

Extremely easy

13.2 (23)

9.3 (11)

21.4 (12)

 

Easy

28.7 (50)

26.3 (31)

33.9 (19)

 

Moderate

35.6 (62)

39.8 (47)

26.8 (15)

 

Difficult

16.1 (28)

16.1 (19)

16.1 (9)

 

Extremely difficult

6.3 (11)

8.5 (10)

1.8 (1)

 
  1. 1 Cells have expected count less than 5. 2Some respondents presented not recorded data, as the question was not asked (dropped from assessments) or they did not complete it.